@article{JTD8712,
author = {Lingling Du and Saiama N. Waqar and Daniel Morgensztern},
title = {Role for adjuvant chemotherapy in patients with resected small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {8},
year = {2016},
keywords = {},
abstract = {Lung cancer is the leading cause of cancer-related mortality in the United States (1). Small cell lung cancer (SCLC) accounts for approximately 13% of all patients with lung cancer (2). SCLC has traditionally been staged using the Veterans’ Affairs Lung Study Group staging system, which subdivides tumors into limited-stage (LS-SCLC) and extensive-stage (ES-SCLC) based on the presence of tumor confinement into one hemithorax and included in one radiotherapy port (3).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/8712}
}